When you buy through links on our articles, Future and its syndication partners may earn a commission.

These athletes will be recognized at a banquet ceremony to be held on Sunday, February 16, 2025, at the Schuylkill ...

Mice injected with a microRNA molecule lived longer and had fewer markers of ageing, but it’s not yet known if the treatment ...

In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...

Highlights from the first day included updates from several firms about their China businesses and M&A strategies.

ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China ImmuneOnc ...

On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and ...